Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Mobico appoints new CFO as NA School Bus sale nears completion

(Sharecast News) - Transport group Mobico has guided to flat profits in 2025, excluding any contribution from the sale of the North American School Bus division, which is expected to complete next month. The news came as the company announced the appointment of finance veteran Brian Egan as its new, permanent chief financial officer, placing Helen Cowing who has served as interim CFO over the past 12 months.

Egan, a chartered accountant, has more than 25 years' CFO experience, having held positions at international outfits including Jefferson Smurfit, Petropavlovsk, Dangote Cement and Coca-Cola.

"We are delighted that Brian will be joining us immediately. His considerable experience working as a CFO for a number of international businesses will serve the Group well and I look forward to working with him," said executive chair Phil White.

The sales of North America School Bus, first announced in late-April for £457m, has made "good progress" in obtaining necessary approvals. The only major approval now needed is from the US Surface Transportation Board, which is said to have already been "tentatively approved and authorised".

Formal STB approval is expected in early July, with the transaction tipped to close shortly after, by which time Mobico will receive upfront net proceeds of £275m-290m, with the remainder due following completion.

"The group continues to have strong liquidity with no significant debt maturities due until the second half of 2027 and the sale of School Bus providing sufficient proceeds to cover those maturities," the company said.

Adjusted operating profits for 2025 are expected to come in the range of £180m-195m, before any contribution from School Bus, with the midpoint more or less in line with the £187.7m reported for 2024.

Shares up were 2.4% at 26.88p in early deals on Tuesday.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.